As biotech turns 20..

Nature Reviews Drug Discovery

Volumn 1, Issue 12, 2002, Pages 1007-1008

  Miller, Henry I ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; RECOMBINANT HUMAN INSULIN;

ANALYTICAL ERROR; ARTICLE; BIOTECHNOLOGY; CONFIDENTIALITY; CONSUMER; COST CONTROL; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SAFETY; DRUG SYNTHESIS; DRUG WITHDRAWAL; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; TAX; UNITED STATES; DRUG COST; ECONOMICS; LEGAL ASPECT; REVIEW;

BIOTECHNOLOGY; DRUG COSTS; DRUG INDUSTRY; HUMANS;

EID: 0036883952     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd965     Document Type: Article

References (11)

1. Altman, L. US Unit backs human insulin for the market. New York Times 1 (October 30, 1982).
2. Boston Consulting Group. The Contribution of Pharmaceutical Companies: What's at Stake for America (Boston Consulting Group, Boston, September 1993).
3. Peck, C. C. Drug development: improving the process. Food Drug Law J. 52, 163-167 (1997).
4. Tufts Center for the Study of Drug Development. Outlook 2002 (Tufts Center for the Study of Drug Development, Boston, 2002).
5. Miller, H. I. To America's Health: A Proposal to Reform the Food and Drug Administration (Hoover Institution Press, Stanford, California, 2000).
6. Shlaes, D. M. & Moellering, R. C. The US Food and Drug Administration and the end of antibiotics. Clin. Infect. Dis. 34, 420-423 (2002).
7. Grabowski, H. G. & Vernon, J. M. The Regulation of Pharmaceuticals (American Enterprise Institute for Public Policy Research, Washington DC, 1983).
8. Zimm, A. Psoriasis drug delay sinks firms' shares. San Jose Mercury News C1 (April 6, 2002).
9. Jaffe, S. Biotech-big pharma betrothals declining. The Scientist 57-58 (July 8, 2002).
10. Anon. Global Pharmaceutical Company Partnering Capabilities Survey. PricewaterhouseCoopers [online] (cited 13 Aug 2002) (2000).
11. Knight, J. Biotech woes set to hit academics. Nature 418, 5 (2002).